Siga Technologies PE Ratio 2011-2025 | SIGA

Current and historical p/e ratio for Siga Technologies (SIGA) from 2011 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Siga Technologies PE ratio as of December 15, 2025 is 6.33.
Siga Technologies PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-12-15 6.32 6.20
2025-09-30 9.15 $1.02 8.97
2025-06-30 6.52 $1.13 5.77
2025-03-31 4.96 $0.67 7.41
2024-12-31 5.44 $0.82 6.64
2024-09-30 6.11 $1.20 5.09
2024-06-30 6.87 $1.17 5.87
2024-03-31 7.75 $1.10 7.05
2023-12-31 4.72 $0.95 4.97
2023-09-30 4.43 $-0.07 0.00
2023-06-30 4.26 $0.39 10.92
2023-03-31 4.48 $0.46 9.74
2022-12-31 5.74 $0.46 12.47
2022-09-30 8.03 $1.45 5.54
2022-06-30 9.02 $0.96 9.40
2022-03-31 5.19 $0.93 5.58
2021-12-31 5.51 $0.92 5.99
2021-09-30 5.41 $0.20 27.06
2021-06-30 4.60 $0.55 8.36
2021-03-31 4.76 $0.81 5.88
2020-12-31 5.32 $0.72 7.39
2020-09-30 5.03 $0.40 12.58
2020-06-30 4.33 $0.06 72.13
2020-03-31 3.50 $-0.25 0.00
2019-12-31 3.49 $-0.16 0.00
2019-09-30 3.75 $0.54 6.94
2019-06-30 4.16 $5.28 0.79
2019-03-31 4.40 $5.24 0.84
2018-12-31 5.78 $5.11 1.13
2018-09-30 5.05 $4.47 1.13
2018-06-30 4.35 $-0.24 0.00
2018-03-31 4.49 $-0.25 0.00
2017-12-31 3.55 $-0.21 0.00
2017-09-30 2.32 $-0.36 0.00
2017-06-30 2.23 $-0.53 0.00
2017-03-31 2.30 $-0.61 0.00
2016-12-31 2.11 $-0.69 0.00
2016-09-30 2.19 $-0.92 0.00
2016-06-30 0.73 $-0.85 0.00
2016-03-31 0.39 $-0.79 0.00
2015-12-31 0.31 $-0.73 0.00
2015-09-30 0.86 $-0.71 0.00
2015-06-30 0.94 $-5.10 0.00
2015-03-31 1.42 $-5.04 0.00
2014-12-31 1.05 $-4.97 0.00
2014-09-30 1.06 $-4.69 0.00
2014-06-30 2.07 $-0.29 0.00
2014-03-31 2.27 $-0.29 0.00
2013-12-31 2.39 $-0.32 0.00
2013-09-30 2.80 $-0.30 0.00
2013-06-30 2.08 $-0.27 0.00
2013-03-31 2.62 $-0.29 0.00
2012-12-31 1.92 $-0.28 0.00
2012-09-30 2.34 $-0.33 0.00
2012-06-30 2.09 $-0.27 0.00
2012-03-31 2.46 $0.25 9.84
2011-12-31 1.85 $0.24 7.69
2011-09-30 2.39 $0.06 39.91
2011-06-30 7.13 $-0.04 0.00
2011-03-31 8.86 $-0.58 0.00
2010-12-31 10.25 $-0.59 0.00
2010-09-30 6.19 $-0.28 0.00
2010-06-30 5.64 $-0.22 0.00
2010-03-31 4.85 $-0.40 0.00
2009-12-31 4.25 $-0.49 0.00
2009-09-30 5.78 $-0.55 0.00
2009-06-30 6.18 $-0.60 0.00
2009-03-31 3.71 $-0.41 0.00
2008-12-31 2.39 $-0.25 0.00
2008-09-30 2.75 $-0.23 0.00
2008-06-30 2.28 $-0.21 0.00
2008-03-31 1.68 $-0.11 0.00
2007-12-31 2.26 $-0.18 0.00
2007-09-30 2.93 $-0.30 0.00
2007-06-30 2.41 $-0.25 0.00
2007-03-31 3.54 $-0.34 0.00
2006-12-31 2.75 $-0.35 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.463B $0.139B
SIGA Technologies Inc. is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents and vaccines to fight potential biowarfare pathogens. With broad technology platforms in both vaccines and antibiotics, SIGA's product development programs emphasize the increasingly serious problem of drug resistant bacteria. In addition to smallpox, SIGA has antiviral programs targeting other Category A pathogens, including arenaviruses, dengue virus, and the filoviruses.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.450B 33.97
Zoetis (ZTS) United States $52.293B 18.72
Takeda Pharmaceutical (TAK) Japan $45.598B 9.31
Daiichi Sankyo, - (DSNKY) Japan $40.539B 20.19
BeOne Medicines - (ONC) Switzerland $37.820B 185.50
Sandoz Group AG (SDZNY) Switzerland $31.838B 0.00
United Therapeutics (UTHR) United States $21.270B 18.72
Merck (MKKGY) Germany $17.881B 11.02
Neurocrine Biosciences (NBIX) United States $15.235B 36.56
Shionogi (SGIOY) Japan $14.445B 13.27
Summit Therapeutics (SMMT) United States $13.549B 0.00
Ionis Pharmaceuticals (IONS) United States $13.091B 0.00
Madrigal Pharmaceuticals (MDGL) United States $12.978B 0.00
IPSEN (IPSEY) France $11.918B 0.00
Orion OYJ (ORINY) Finland $9.738B 27.82
Corcept Therapeutics (CORT) United States $9.256B 99.99
Eisai (ESAIY) $8.400B 0.00
Stevanato Group S.p.A (STVN) Italy $6.305B 35.29
Grifols, S.A (GRFS) Spain $6.284B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.238B 18.97
Crinetics Pharmaceuticals (CRNX) United States $4.791B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.544B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.224B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.838B 18.22
Centessa Pharmaceuticals (CNTA) United Kingdom $3.564B 0.00
Ocular Therapeutix (OCUL) United States $3.102B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.903B 9.26
Soleno Therapeutics (SLNO) United States $2.793B 0.00
Dyne Therapeutics (DYN) United States $2.752B 0.00
Hypermarcas (HYPMY) Brazil $2.737B 18.79
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.090B 24.77
Avadel Pharmaceuticals (AVDL) Ireland $2.086B 0.00
Guardian Pharmacy Services (GRDN) United States $1.911B 36.81
Harrow (HROW) United States $1.743B 106.96
BioCryst Pharmaceuticals (BCRX) United States $1.594B 94.62
Collegium Pharmaceutical (COLL) United States $1.537B 7.61
Ardelyx (ARDX) United States $1.509B 0.00
Oruka Therapeutics (ORKA) United States $1.461B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.439B 0.00
Savara (SVRA) United States $1.408B 0.00
Relay Therapeutics (RLAY) United States $1.392B 0.00
Cronos Group (CRON) Canada $1.250B 0.00
Xeris Biopharma Holdings (XERS) United States $1.190B 0.00
Xencor (XNCR) United States $1.180B 0.00
Nektar Therapeutics (NKTR) United States $1.113B 0.00
Evotec AG (EVO) Germany $1.069B 0.00
ARS Pharmaceuticals (SPRY) United States $1.012B 0.00
Enliven Therapeutics (ELVN) United States $1.001B 0.00
Theravance Biopharma (TBPH) United States $0.921B 38.66
Esperion Therapeutics (ESPR) United States $0.920B 0.00
KalVista Pharmaceuticals (KALV) United States $0.855B 0.00
Aquestive Therapeutics (AQST) United States $0.758B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.740B 6.61
Lyell Immunopharma (LYEL) United States $0.732B 0.00
Lexeo Therapeutics (LXEO) United States $0.713B 0.00
ProKidney (PROK) United States $0.665B 0.00
Bioventus (BVS) United States $0.625B 12.80
4D Molecular Therapeutics (FDMT) United States $0.619B 0.00
Organogenesis (ORGO) United States $0.612B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.582B 13.77
Altimmune (ALT) United States $0.550B 0.00
Elite Pharmaceuticals (ELTP) United States $0.537B 0.00
Zevra Therapeutics (ZVRA) United States $0.469B 0.00
Akebia Therapeutics (AKBA) United States $0.441B 0.00
Galectin Therapeutics (GALT) United States $0.403B 0.00
Nature's Sunshine Products (NATR) United States $0.398B 23.69
USANA Health Sciences (USNA) United States $0.373B 10.42
Aclaris Therapeutics (ACRS) United States $0.352B 0.00
Avalo Therapeutics (AVTX) United States $0.337B 0.00
Larimar Therapeutics (LRMR) United States $0.335B 0.00
OmniAb (OABI) United States $0.310B 0.00
Fractyl Health (GUTS) United States $0.307B 0.00
Silence Therapeutics (SLN) United Kingdom $0.299B 0.00
Relmada Therapeutics (RLMD) United States $0.298B 0.00
Protara Therapeutics (TARA) United States $0.294B 0.00
Aldeyra Therapeutics (ALDX) United States $0.273B 0.00
Pyxis Oncology (PYXS) United States $0.268B 0.00
Heron Therapeutics (HRTX) United States $0.251B 0.00
Achieve Life Sciences (ACHV) Canada $0.247B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.227B 0.00
Profound Medical (PROF) Canada $0.221B 0.00
MediWound (MDWD) Israel $0.211B 0.00
Surrozen (SRZN) United States $0.211B 0.00
Journey Medical (DERM) United States $0.208B 0.00
AleAnna (ANNA) United States $0.196B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.170B 0.00
China SXT Pharmaceuticals (SXTC) China $0.164B 0.00
Innate Pharma SA (IPHYF) France $0.160B 0.00
Gain Therapeutics (GANX) United States $0.159B 0.00
Incannex Healthcare (IXHL) Australia $0.146B 0.00
Cassava Sciences (SAVA) United States $0.142B 0.00
Unicycive Therapeutics (UNCY) United States $0.134B 0.00
Karyopharm Therapeutics (KPTI) United States $0.119B 0.00
Inhibikase Therapeutics (IKT) United States $0.116B 0.00
Prelude Therapeutics (PRLD) United States $0.108B 0.00
Cardiol Therapeutics (CRDL) Canada $0.107B 0.00
Avita Medical (RCEL) United States $0.106B 0.00
Vivani Medical (VANI) United States $0.098B 0.00
Context Therapeutics (CNTX) United States $0.096B 0.00
Plus Therapeutics (PSTV) United States $0.094B 0.00
Champions Oncology (CSBR) United States $0.093B 33.60
VAXART, INC (VXRT) United States $0.089B 0.00
Acrivon Therapeutics (ACRV) United States $0.080B 0.00
Korro Bio (KRRO) United States $0.078B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.077B 0.00
Rafael Holdings (RFL) United States $0.076B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.075B 0.00
Assertio Holdings (ASRT) United States $0.073B 0.00
Dominari Holdings (DOMH) United States $0.071B 0.00
PMV Pharmaceuticals (PMVP) United States $0.065B 0.00
Lite Strategy (LITS) United States $0.063B 0.00
PolyPid (PYPD) Israel $0.062B 0.00
Nutriband (NTRB) United States $0.062B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Arch Biopartners (ACHFF) Canada $0.061B 0.00
NRx Pharmaceuticals (NRXP) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
BioNxt Solutions (BNXTF) Canada $0.057B 0.00
Talphera (TLPH) United States $0.055B 0.00
Wellgistics Health (WGRX) United States $0.051B 0.00
Telomir Pharmaceuticals (TELO) United States $0.050B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Jupiter Neurosciences (JUNS) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.038B 31.62
Mural Oncology (MURA) Ireland $0.035B 0.00
FibroGen (FGEN) United States $0.034B 0.00
Klotho Neurosciences (KLTO) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Inotiv (NOTV) United States $0.026B 0.00
Vyome Holdings (HIND) United States $0.026B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.025B 0.00
Iterum Therapeutics (ITRM) Ireland $0.024B 0.00
Liminatus Pharma (LIMN) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
TherapeuticsMD (TXMD) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.019B 0.00
Citius Pharmaceuticals (CTXR) United States $0.019B 0.00
Traws Pharma (TRAW) United States $0.019B 0.02
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Mangoceuticals (MGRX) United States $0.016B 0.00
Cosmos Health (COSM) United States $0.015B 0.00
Tempest Therapeutics (TPST) United States $0.015B 0.00
Heatwurx (PCSA) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.013B 0.00
VYNE Therapeutics (VYNE) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
CASI Pharmaceuticals (CASI) China $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Alaunos Therapeutics (TCRT) United States $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
ProPhase Labs (PRPH) United States $0.005B 0.00
Jaguar Animal Health (JAGX) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
CDT Equity (CDT) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 18.14
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00